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 Summary
 Background: To evaluate the role of HRCT in quantifying emphysema in severe COPD patients and to study 
the variations in the pattern of emphysema in relation to age, sex, FEV1, smoking index, biomass 
exposure, and BMI.
 Material/Methods: Automatic lung segmentation of HRCT scans in 41 severe COPD patients (GOLD stage III or more) 
was done using an emphysema protocol. The extent of emphysema was assessed using the density 
mask method with a threshold of –950 HU (%LAA-950). The percentage of emphysema in each lung 
lobe and both lungs was correlated with 6 parameters – age, sex, BMI, smoking index, biomass 
exposure, and FEV1.
 Results: Smoking resulted in homogenously distributed emphysema regardless of the severity of smoking. 
BMI was inversely correlated with the extent of emphysema. A significant association was found 
between the percentage of emphysema in the right lower lobe and BMI (P=0.015), between biomass 
exposure and the percentage of emphysema in RUL, RLL, and both lungs (P values of 0.024, 0.016, 
and 0.036, respectively). The extent of emphysema was disproportionately low compared to the 
amount of obstruction on PFTs, indicating an airway predominant variety of COPD with significant 
biomass exposure.
 Conclusions: Smoking is associated with a relatively homogenous distribution of emphysema with no regional 
predilection. Biomass exposure produces predominantly right-sided emphysema. BMI decreases 
with increasing levels of emphysema in the right lower lobe. These risk factors of emphysema 
patterns are helpful in deciding on the management, including surgical options.
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Background
Chronic obstructive pulmonary disease (COPD) is the fourth 
leading cause of death in the world and is poised to become 
the third leading cause of death worldwide in 2030 [1,2]. 
The most widely used and accepted COPD guidelines is 
“The Global Initiative for Chronic Obstructive Lung Disease 
(GOLD)”. GOLD defines COPD as “a common preventable 
and treatable disease characterized by persistent airflow 
limitation that is usually progressive and associated with 
an enhanced chronic inflammatory response in the airways 
and lungs to noxious particles and gases. Exacerbations 
and co-morbidities contribute to overall severity in the 
individual patient”. Smoking remains the major risk factor 
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for COPD. Biomass exposure is also a significant risk factor, 
especially in rural areas.
COPD manifests differently in individuals. This has led to the 
emergence of the concept of “phenotype” in COPD. The term 
phenotype in the field of COPD refers to the predominant set 
of disease features that show variations in their presence 
in different individuals and which are significant enough to 
affect the prognosis and clinical outcome. Based on this con-
cept, numerous clinical and radiological phenotypes of COPD 
have been described, which have different prognoses and 
outcomes and hence merit different treatment approaches.
Once a diagnosis of COPD is made, numerous modalities are 
used to assess the severity and monitor the progress and 
treatment response in COPD. These include spirometry, dif-
fusing capacity, arterial blood gas analysis, and radiological 
modalities like X-ray and computed tomography (CT). CT 
is superior to chest radiography in the detection of emphy-
sema and in the assessment of its distribution and extent. 
Morphologically, two main subtypes of emphysema exist. 
The centrilobular (or centriacinar) form of emphysema 
results from dilatation or destruction of the respiratory bron-
chioles and is the type of emphysema most closely associated 
with cigarette smoking. The panlobular (or panacinar) form 
of emphysema is associated with a1-antitrypsin deficiency 
and results in an even dilatation and destruction of the entire 
acinus. Emphysema will be visible in many conventional CT 
sections with thicknesses of 5 to 8 mm. However, it is more 
readily detected on high-resolution CT (HRCT) sections with 
thicknesses of 1 to 2 mm that are reconstructed with an edge 
enhancing algorithm. Advances in CT have enabled localiz-
ing, quantifying, prognosticating, and phenotyping COPD. 
Stratification of treatment of COPD into medical and surgical 
categories is also well accomplished by CT.
In the present study, a quantitative analysis of thoracic 
HRCT scans was done in patients with stable GOLD stage 3 
or 4 COPD, and the percentage of emphysema in each lobe 
of both lungs and the total extent of emphysema was cor-
related with 6 parameters – age, sex, BMI, smoking index, 
biomass exposure, FEV1.
Material and Methods
Patients
This study involved 41 stable COPD patients attend-
ing the Medicine and Pulmonary Medicine Departments. 
Only severe COPD (GOLD stage III or more) patients diag-
nosed by the post-bronchodilator FEV1/FVC <0.7 and FEV1 
<50% of predicted values were included in this study. The 
approval of the local ethical committee was sought for the 
study protocol, and the informed consent was taken from 
all patients before the examination. A brief history, rel-
evant physical examination, and quick review of records, 
including chest X-rays, was done.
CT scan
CT scans were done on 64-slice MDCT scanner (Lightspeed 
VCT-XTE, GE medical systems) with the following param-
eters: kvp: 120 kvp, mAs: 335 mAs, Gantry rotation time: 0.6 
secs, Gantry tilt: 0 degree, Slice thickness: 0.6mm, Total radi-
ation dose: 4.498 mSV. The high resolution CT images were 
acquired at suspended full inspiration using the smallest FOV 
(Field Of View) that included both lungs. On completion of 
CT scanning, the data were transferred to a real-time inter-
active 3D Workstation: Advantage Window version 4.5, GE 
Healthcare. Images were reconstructed using the recommend-
ed reconstruction kernel for thoracic VCAR, which is BONE 
or STANDARD. In addition, volume rendering (VR), maximum 
and minimum intensity projections (MIP and minIP) in stand-
ard axial, coronal, sagittal, and oblique reformatted images 
were obtained. Axial source data was analyzed in all cases.
Post-processing
It was done in a pre-installed post-processing application/
software, i.e., Thoracic VCAR. Thoracic VCAR is a non-
invasive CT image analysis software package, which may 
be used in conjunction with CT lung images to aid in the 
assessment of thoracic disease (emphysema, COPD) diagno-
sis and management. The emphysema protocol within the 
software provided automatic segmentation of the lungs. 
The lobe segmentation protocol divided the lungs into sev-
eral lobes. The software provided quantification of HU val-
ues and displayed in color (blue) the thresholds within a 
segmented region. Thoracic VCAR application supports CT 
datasets, high resolution scans, or volume scans.
Image analysis
The extent of emphysema was assessed using the density 
mask method to get the percentage of lung voxels with a 
density lower than a certain threshold. This was expressed 
using the term%LAA (percentage low attenuation areas) to 
describe these low density regions of the lung. A threshold 
of -950 Hounsfield Units (HU) was used as the primary cut-
off (%LAA-950) to obtain color-coded display of abnormal 
emphysematous regions in both lungs. The volume infor-
mation of the left lung, right lung, both lungs, and each 
lobe of each lung was analyzed and displayed in the statis-
tics panel, which was recorded in the final report. Airway 
analysis was not done due to lack of achieving a uniform 
level of airway tracking in all patients with the installed 
version of the software.
Statistical Analysis
The percentage of emphysema in each lobe of both lungs 
and the total emphysema extent were correlated with 6 
parameters – age, sex, BMI, smoking index, biomass expo-
sure, FEV1. P value was calculated for each association. 
The test used to determine the statistical significance was 
ANOVA (analysis of variance).
Results
The age of patients ranged between 42 years to 82 years, 
with the mean age of 62.53 (SD±10.17) years. There was 
male predominance in our study. There were 34 (82.92%) 
males and 7 (17.07%) females in this study. The mean BMI 
of the patients was 18.14 (SD±3.01). The minimum BMI 
was 13.67, while the maximum BMI was 25.11. Smoking 
was the most common associated risk factor and was 
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present in all 41 patients (100%). Smoking index was used 
as a measure of severity of smoking and also as a tool for 
stratifying patients into groups. Smoking index was defined 
as the number of cigarettes/bidis smoked per day multi-
plied by the duration of smoking. The mean smoking index 
was 568.65 (SD±355.12). There was a relatively homoge-
nous distribution of emphysema in both lungs regardless of 
the severity of smoking. Exposure to smoke from biomass 
fuels was present in 9 patients (21.95%). Of those exposed, 
only 2 were males (4.8%), while the remaining 7 were 
females (17.07%). Minimum FEV1 was 0.32, while the max-
imum FEV1 was 1.47. The mean FEV1 was 0.74 (SD±0.26).
The range, mean, and the standard deviations of the percent-
age of emphysema in each lung lobe are depicted in Table 1.
Statistical significance was sought for the relation-
ship between each of the 5 parameters and percentage of 
emphysema distribution on quantitative HRCT. The P val-
ues for these associations are depicted in Table 2.
A statistically significant association was found between 
the percentage of emphysema in the right lower lobe and 
BMI (P value=0.015). There was an inverse correlation 
between BMI and the percentage of emphysema. A sta-
tistically significant association was found between bio-
mass exposure and percentage of emphysema in the right 
upper lobe, right lower lobe, and the total percentage of 
emphysema in both lungs. P values for these associations 
were 0.024, 0.016, and 0.036, respectively. The amount of 
emphysema was disproportionately low compared to the 
degree of obstruction demonstrated by spirometry. This 
was suggestive of an airway predominant variety of COPD 
affecting the patients with significant biomass exposure.
No statistically significant association was found between 
age, sex, FEV1, and the percentage of emphysema in any 
lobe of both lungs.
Below, we present HRCT findings of representative cases in 
the present study (Figures 1–4).
RUL RML RLL LUL LLL Total
Mean 16.02 7.96 7.68 16.94 8.13 13
SD 17.32 12.92 12.85 18.86 11.83 13.05
Maximum 69.29 60.05 65.4 66.37 60.93 45.17
Minimum 0.06 0 0.02 0.01 0.05 0.08
Table 1. Lobar and total distribution of emphysema (in percent) in all the cases.
RUL RML RLL LUL LLL Total
Age 0.519 0.631 0.378 0.098 0.754 0.337
BMI 0.495 0.198 0.015 0.37 0.057 0.240
Smoking Index 0.512 0.398 0.344 0.239 0.208 0.222
Biomass exposure 0.024 0.079 0.016 0.086 0.404 0.036
FEV1 0.496 0.366 0.203 0.897 0.873 0.589
Table 2.  P values for statistical association between age, BMI, smoking index, biomass exposure, FEV1 and percentage of emphysema, both lobar 
and total.
Figure 1.  Large emphysematous regions in the right lower lobe on HRCT and post-processed color-coded HRCT images.
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Discussion
Chronic obstructive pulmonary disease (COPD) is one of 
the leading causes of morbidity and mortality worldwide. 
COPD is characterized by irreversible airflow obstruction. 
It is a complex disease affecting the airways (e.g. chronic 
bronchitis, airway collapse), the parenchyma (e.g. hyper-
inflation, air trapping, and emphysematous destruction) as 
well as the vasculature (e.g. hypoxic vasoconstriction, pul-
monary arterial hypertension) with differing severity dur-
ing the course of the disease.
Spirometry has been the workhorse for the diagnosis of COPD 
for decades. However, its inherent limitation of not being able 
to distinguish airway from parenchyma as the source of dis-
ease has led to the use of imaging modalities like CT in COPD. 
Advances in CT have enabled localizing, quantifying, prognos-
ticating, and phenotyping COPD. Stratification of treatment of 
COPD into medical and surgical categories is also well accom-
plished by CT. This study was undertaken to identify the vari-
ous risk factors and their association with CT-based assess-
ment of emphysema extent. Correlation between spirometric 
and quantitative CT results was also tested for any detect-
able pattern. Subjective evaluation was done by color coding 
(blue) of the emphysematous regions and comparing it with 
non-color-coded lung window images. This was followed by 
generating tabulated quantitative estimates of emphysema in 
each lobe of both lungs. This quantitative data were used for 
statistical analysis in order to derive meaningful relationship 
between the distribution of emphysema and other parame-
ters like age, sex, smoking, biomass exposure, PFTs, and BMI. 
These relationships are discussed further.
Figure 2.  Comparative assessment of non-color-coded and color-coded HRCT images in severe COPD.
Figure 3.  Scantily distributed areas of emphysema are shown in blue.
Range Name
–950 HU
>–950 HU
Range values
[–1024/–950]
[–950/3071]
Total
Total Lung Volume
Combined Lungs
7.5335%/0.396 L
92.4665%/4.8605 L
5.2565 L
Right Lung
Right Lung
3.1865%
96.8135%
2.6344 L
Upper Lobe
3.7348%
96.2652%
1.3394 L
Middle Lobe
5.2485%
94.7515%
0.39 L
Left Lung
Left Lung
11.9009%
88.0991%
2.6221 L
Upper Lobe
9.3548%
90.6452%
1.4202 L
Middle Lobe
14.9098%
85.0902%
1.2019 L
Lowrer Lobe
1.4865%
98.5135%
0.905 L
Figure 4.  Computer generated quantitative CT report.
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Age
The incidence of centrilobular and panacinar emphy-
sema increases with age and is most frequently found in 
patients in the seventh decade of life. Consequently, there 
is a decrease in the incidence of centrilobular emphysema 
[3]. There was no significant association between the dis-
tribution or severity of emphysema and any particular age 
group in this study. The contemporary literature on COPD 
indicates an increasing age as a significant predictor of 
morbidity in COPD. The largest study on COPD to date, the 
COPDGene study, studied CT scans and spirometric results 
of 9,317 participants, and it helped in formulating a score 
called EMPHASIZE (EMPHysema, Age, Smoking, SIZE). 
This score incorporates age as one the factors in predicting 
the presence of clinically significant COPD and future mor-
bidity [4]. The likely reason for the discordance between 
the present study and COPDGene study with regard to the 
association between age and severity of COPD may be the 
inclusion of airway wall measurements along with paren-
chymal changes in the latter, while our study included only 
parenchymal emphysematous changes.
Sex distribution
COPD predominantly affects males [5]. This is believed to 
be due to a relatively increased incidence of smoking in 
males rather than to any gender driven susceptibility. Jain 
et al. (2011) studied the impact of gender on the expres-
sion of COPD in the Indian population. They concluded 
that, in comparison to males, females were younger, had 
more dyspnea, more severe bronchial obstruction, more 
exacerbations, and a higher prevalence of systemic fea-
tures. Tobacco smoke in the form of bidi smoking was the 
predominant smoke exposure in males, whereas smoke 
from biomass fuel burning was the predominant exposure 
in females. Males were more likely than females to have 
an emphysema-predominant phenotype, while airway-pre-
dominant disease was more common among females [6].
Our study also resonates with the majority of these find-
ings. All female patients in this study had significant bio-
mass exposure (for at least 20 years). Of the 9 patients with 
biomass exposure, 7 were females. The mean percentage of 
emphysema was small in all lobes in females (3.61%) than 
males (12.94%) despite equally severe obstruction on PFTs 
in both males and females. This indirectly points towards 
a large proportion of airway predominant abnormality in 
females when compared to males, which would require 
quantitative airway evaluation for confirmation. There 
was no gender predilection for emphysema in any specific 
lung lobe in both groups.
Smoking
Smoking is the commonest risk factor for COPD. Airway 
inflammation does not resolve in COPD patients even after 
smoking abstinence, and it can even increase in some 
aspects [7]. A recently suggested hypothesis is that COPD 
may have an autoimmune component which contributes 
to the airway inflammation even after smoking cessation 
[8]. These auto-antibodies may be directed against antigens 
present in tobacco or against endogenous auto-antigens 
that result from smoking-induced inflammatory and oxida-
tive lung injury [9].
One recent study addressing this issue reported that 50% of 
smokers eventually develop COPD, as defined by the Global 
Initiative for Chronic Obstructive Lung Disease (GOLD) 
guidelines. This finding is of major clinical significance in 
that it provides a scientific basis for the advice that can 
now be given to smokers that if they continue smoking life-
long, they have at least a one in two chances of develop-
ing COPD [10]. All 41 patients in our study had history of 
smoking. Quantification of smoking for grading the sever-
ity of exposure in the Indian population was done as early 
as 1988 by Jindal et al., wherein they formulated a smok-
ing index to express cumulative smoking exposure. This is 
especially useful in defining the risk of a smoking-related 
disease. The parameter is similar to “Pack Year” but more 
suitable to Indian subjects [11].
It was widely believed that the main emphysema subtype 
among smokers, CLE (centrilobular emphysema), is pri-
marily located in the upper lung zones. However, most of 
the references for this statement were based on subjective 
scoring of the extent of emphysema [12]. With the advent of 
quantitative CT, the studies based on objective and quanti-
tative CT measurements indicate a homogeneous distribu-
tion or lower lobe distribution of emphysema in smokers 
[13]. In our study, there was no significant predilection for 
emphysema in any specific lobe in smokers, thereby sug-
gesting a relatively homogenous distribution.
Pulmonary function tests
Although PFTs are both short- and long-term reproducible 
tests, they represent global measurements of obstruction of 
small airways in emphysema. Autopsy studies have shown 
that up to one third of lungs can be destroyed without 
changes in respiratory function [14]. Our study did not find 
any statistically significant association between FEV1 and 
the percentage of emphysema in any specific lobe of both 
lungs. There are two possible reasons for this discordance. 
One is the relative insensitivity of PFTs towards low lev-
els of lung parenchymal destruction, as discussed earlier. 
Secondly, this study did not include assessment of airways 
in quantitative CT evaluation, which could have been the 
predominant cause of severe obstruction on PFTs and rela-
tively less severe on CT. In the COPDGene study, CT meas-
ures of air trapping correlated best with the FEV1 and the 
FEV1/FVC [4]. In 2014, Firdaus et al. found that FEV1 and 
the FEV1/FVC correlated best with airway wall thickness 
and emphysema, respectively [15].
Biomass exposure
Exposure to smoke from biomass fuels was present in 
9 patients (21.95%) in our study. Of those exposed, only 
2 were males (4.8%), while the remaining 7 were females 
(17.07%). There was a statistically significant correlation 
between biomass exposure and percentage of emphysema 
in the right upper and lower lobe. The reason for this local-
ized association could not be determined.
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Although information is scarce, over the past few years, a 
clear picture of the main characteristics of biomass smoke-
associated COPD (BSCOPD) has emerged. This allows for 
comparison with many aspects of the better understood 
COPD caused by tobacco/cigarette smoking (TSCOPD), thus 
forming two clearly separate COPD phenotypes. Bronchial 
hyperreactivity, airflow obstruction, chronic bronchitis, 
and unusually low levels of emphysema are the predomi-
nant features of BSCOPD. Thus, BSCOPD is an airway pre-
dominant phenotype of COPD [16].
Body mass index
Body mass index is a universal measure of nutritional sta-
tus of an individual. Hence, it has been used extensively in 
numerous studies to demonstrate any association between 
the nutritional status and the disease under consideration. 
COPD is no exception. There has been a resounding uni-
formity in the conclusions of multiple studies comparing 
BMI and emphysema. Quantity of emphysema is inversely 
proportional to BMI [17–19].
In our study, the mean BMI was 18.14 (SD±3.01) kg/m2. 
The lowest BMI was 13.67 kg/m2, while the highest BMI 
was 25.11 kg/m2. There was a statistically significant asso-
ciation between BMI and the percentage of emphysema in 
the right lower lobe (p=0.015). However, the exclusive pre-
dilection for the right lower lobe could not be explained.
An accepted explanation of weight loss is excess energy 
expenditure due to the increased energy needed for breath-
ing secondary to COPD. Atrophy of skeletal muscles is gen-
erally the main cause of weight loss in established COPD. 
COPD has recently been recognized as a systemic dis-
ease. Systemic inflammation may be a pathogenic factor 
that could explain the loss of weight in our subjects. The 
inflammation in the lungs due to cigarette smoking may 
induce emphysema and weight loss before the airflow limi-
tation is measurable by spirometry [18].
Dose reduction strategies in COPD quantification – A stand-
ard dose CT-based emphysema quantification (150 mAs) 
was compared with a low-dose CT (25 mAs) protocol cou-
pled with adaptive iterative dose reduction using 3D pro-
cessing by Nishio et al. in 2012 [20]. They found greater 
consistency in quantification of emphysema by low-dose 
CT than standard-dose CT due to the use of adaptive itera-
tive dose reduction using 3D processing in the former. This 
is definitely encouraging in addressing the issues of radia-
tion risk associated with CT and needs a worthy look in 
future.
Quantitative CT in emphysema harbors the potential to 
understand the heterogeneity of the disease process based 
on risk factors and is being studied for its utility in catego-
rizing disease phenotype and thus stratifying patients into 
better candidates for treatment options like novel pharma-
ceutical agents and surgery [21].
Conclusions
Quantitative HRCT is an emerging and powerful tool to 
quantify, prognosticate, and stratify patients into catego-
ries which acknowledge the exact severity and distribution 
of emphysema. Biomass exposure produces predominantly 
right-sided emphysema. BMI decreases in proportion to 
increasing levels of emphysema in the right lower lobe. 
Smoking remains the most common risk factor for emphy-
sema and displays relatively homogenous emphysema dis-
tribution with no specific predilection for any particular 
lobe. These risk factors of emphysema patterns can be 
helpful in selecting proper management.
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